{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:28:30Z","timestamp":1791350910314,"version":"4.3.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jaci.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T17:23:00Z","timestamp":1461950580000},"page":"1651-1661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Role of IgE in autoimmunity"],"prefix":"10.1016","volume":"137","author":[{"given":"Miguel A.","family":"Sanjuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kolbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2016.04.007_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri2992","article-title":"Diversity and dialogue in immunity to helminths","volume":"11","author":"Allen","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2016.04.007_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nature11047","article-title":"Allergic host defences","volume":"484","author":"Palm","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2016.04.007_bib4","first-page":"245","article-title":"The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus","volume":"86C","author":"Permin","year":"1978","journal-title":"Acta Pathol Microbiol Scand C"},{"key":"10.1016\/j.jaci.2016.04.007_bib5","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1590\/S0100-879X2004001000008","article-title":"Immunoglobulin E and systemic lupus erythematosus","volume":"37","author":"Atta","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jaci.2016.04.007_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000167202","article-title":"Increased serum IgE levels in patients with lupus nephritis","volume":"6","author":"Laurent","year":"1986","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jaci.2016.04.007_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.6061\/clinics\/2012(11)09","article-title":"Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus","volume":"67","author":"Liphaus","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.jaci.2016.04.007_bib8","first-page":"34","article-title":"Systemic lupus erythematosus activity and IgE","volume":"50","author":"Rebhun","year":"1983","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2016.04.007_bib9","first-page":"94","article-title":"Serum IgE concentrations, disease activity, and atopic disorders in systemic lupus erythematosus","volume":"50","author":"Elkayam","year":"1995","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.04.007_bib10","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1177\/0961203310379870","article-title":"Total serum IgE levels in systemic lupus erythematosus and associations with childhood onset\u00a0allergies","volume":"19","author":"Parks","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaci.2016.04.007_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/0962935031000097709","article-title":"Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients","volume":"12","author":"Wozniacka","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaci.2016.04.007_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/ard.57.11.660","article-title":"IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus","volume":"57","author":"Morton","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2016.04.007_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.gpb.2015.09.001","article-title":"Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus","volume":"13","author":"Zhu","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.jaci.2016.04.007_bib14","doi-asserted-by":"crossref","first-page":"e90424","DOI":"10.1371\/journal.pone.0090424","article-title":"Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis","volume":"9","author":"Dema","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2016.04.007_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3326","article-title":"Self-reactive IgE exacerbates interferon responses associated with autoimmunity","volume":"17","author":"Henault","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1398-9995.2011.02581.x","article-title":"Auto-reactive IgE responses to acidic ribosomal\u00a0P(2) protein in systemic lupus erythematosus","volume":"66","author":"Rhyner","year":"2011","journal-title":"Allergy"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2016.04.007_bib17","first-page":"154","article-title":"Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients","volume":"161","author":"Hatada","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib18","first-page":"577","article-title":"IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity","volume":"42","author":"Dopp","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib20","first-page":"293","article-title":"IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria","volume":"25","author":"Concha","year":"2004","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2016.04.007_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000288293","article-title":"Sousa Atta ML. Autoimmune response of IgE antibodies to cellular self-antigens in systemic lupus erythematosus","volume":"152","author":"Atta","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1084\/jem.20140066","article-title":"Immunoglobulin E plays an immunoregulatory role in lupus","volume":"211","author":"Dema","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/art.1780241120","article-title":"Systemic lupus erythematosus with only IgE-class antinuclear antibodies","volume":"24","author":"Barone","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2016.04.007_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2016.04.007_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/hyb.2011.0102","article-title":"Functional\u00a0characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180","volume":"31","author":"Messingham","year":"2012","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/j.jaci.2016.04.007_bib26","doi-asserted-by":"crossref","first-page":"e14794","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase\u2014a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2016.04.007_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/ard.52.1.14","article-title":"Significance of enzyme linked immunosorbent assay (ELISA) for antibodies\u00a0to\u00a0double stranded and single stranded DNA in patients with lupus nephritis:\u00a0correlation with severity of renal histology","volume":"52","author":"Okamura","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2016.04.007_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000166485","article-title":"Glomerular IgE deposits in patients with lupus nephritis","volume":"1","author":"Tuma","year":"1981","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jaci.2016.04.007_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5858\/133.2.233","article-title":"Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications","volume":"133","author":"Seshan","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.rdc.2009.12.008","article-title":"Interferon-alpha: a therapeutic target in systemic lupus erythematosus","volume":"36","author":"Crow","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaci.2016.04.007_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to\u00a0severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","author":"Khamashta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2016.04.007_bib33","article-title":"Anifrolumab, an anti-interferon alpha receptor monoclonal antibody, in moderate\u00a0to severe systemic lupus erythematosus (SLE) [Abstract]","volume":"67","author":"Furie","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib34","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaci.2016.04.007_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0961203308090020","article-title":"The innate immune system in SLE: type I interferons and dendritic cells","volume":"17","author":"Ronnblom","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaci.2016.04.007_bib36","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids\u00a0in\u00a0viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2016.04.007_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.immuni.2011.10.009","article-title":"Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation","volume":"35","author":"Mouchess","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2016.04.007_bib41","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.171.6.3296","article-title":"Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG","volume":"171","author":"Bave","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000234742","article-title":"Interaction of IgE with its high-affinity receptor. Structural basis and requirements for effective cross-linking","volume":"88","author":"Baird","year":"1989","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib43","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.135.5.3348","article-title":"Two distinct classes of IgG Fc receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength","volume":"135","author":"Jones","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaci.2004.05.038","article-title":"Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis","volume":"114","author":"Novak","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib45","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.4049\/jimmunol.0901194","article-title":"Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells","volume":"184","author":"Gill","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2007.09.049","article-title":"Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha","volume":"121","author":"Schroeder","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib47","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost\u00a0to prevent fall asthma exacerbations","volume":"136","author":"Teach","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib48","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.4049\/jimmunol.1301908","article-title":"IFN-alpha suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells","volume":"192","author":"Huber","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4049\/jimmunol.1000469","article-title":"Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3","volume":"185","author":"Huber","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib50","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.V87.6.2354.bloodjournal8762354","article-title":"Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators","volume":"87","author":"Aldebert","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.04.007_bib51","first-page":"606","article-title":"Interferon-alpha\/beta inhibits IgE-dependent histamine release from rat mast cells","volume":"66","author":"Swieter","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2016.04.007_bib52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jaci.2003.08.027","article-title":"IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release","volume":"112","author":"Chen","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib53","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.4049\/jimmunol.1200968","article-title":"Fcgamma receptors inhibit mouse and human basophil activation","volume":"189","author":"Cassard","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000233200","article-title":"Detection of basophil sensitization by IgE antibodies to nuclear antigens in connective tissue diseases","volume":"69","author":"Camussi","year":"1982","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.2159","article-title":"Basophils and the T helper 2 environment can promote the development of lupus nephritis","volume":"16","author":"Charles","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib56","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.4049\/jimmunol.1002319","article-title":"Basophils support the survival of plasma cells in mice","volume":"185","author":"Rodriguez Gomez","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2016.04.007_bib58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molmed.2013.06.003","article-title":"Emerging treatments for pemphigoid diseases","volume":"19","author":"Ludwig","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib59","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.2003.12146.x","article-title":"Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid","volume":"120","author":"Dimson","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12026-014-8547-7","article-title":"Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid","volume":"59","author":"Messingham","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaci.2016.04.007_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1523-1747.ep12505711","article-title":"Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient","volume":"78","author":"Dvorak","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197802232980803","article-title":"Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid","volume":"298","author":"Wintroub","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib63","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A\u00a0pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib64","first-page":"193","article-title":"Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin","volume":"18","author":"Provost","year":"1974","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib65","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab\u00a0therapy for bullous pemphigoid","volume":"71","author":"Yu","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib67","first-page":"e1","article-title":"Methods report on the development of the 2013 revision and update of the EAACI\/GA2 LEN\/EDF\/WAO guideline for the definition, classification, diagnosis, and management of urticaria","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.04.007_bib68","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1365-2222.2010.03582.x","article-title":"Serum total tryptase levels are increased in patients with active chronic urticaria","volume":"40","author":"Ferrer","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.04.007_bib69","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2016.04.007_bib70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A\u00a0randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.12.1342","article-title":"Omalizumab\u00a0for\u00a0the\u00a0treatment of chronic spontaneous urticaria: a meta-analysis of randomized\u00a0clinical trials","author":"Zhao","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib72","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cea.12673","article-title":"Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus\u2014a systematic review","volume":"46","author":"Kolkhir","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.04.007_bib73","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11882-013-0366-8","article-title":"Urticaria and autoimmunity: where are we now?","volume":"13","author":"Stitt","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2016.04.007_bib74","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2230.2005.02039.x","article-title":"HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria","volume":"31","author":"Aydogan","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib75","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2133.1999.02815.x","article-title":"Human leucocyte antigen class II associations in chronic idiopathic urticaria","volume":"140","author":"O'Donnell","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib76","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2012.01.043","article-title":"Chronic urticaria and autoimmunity: associations found in a large population study","volume":"129","author":"Confino-Cohen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib77","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1398-9995.2009.02132.x","article-title":"EAACI\/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria","volume":"64","author":"Konstantinou","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.04.007_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2014.04.036","article-title":"The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria","volume":"135","author":"Chang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib79","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/jid.2008.80","article-title":"Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis","volume":"128","author":"Altrichter","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1020516029883","article-title":"The importance of specific IgG and IgE autoantibodies to retinal S antigen, total serum IgE, and sCD23 levels in autoimmune and infectious uveitis","volume":"19","author":"Muino","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib81","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/sji.12200","article-title":"CD3G\u00a0gene\u00a0defects in familial autoimmune thyroiditis","volume":"80","author":"Gokturk","year":"2014","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.48.3.201","article-title":"Anti-IgE autoantibodies in systemic sclerosis (scleroderma)","volume":"48","author":"Kaufman","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2016.04.007_bib83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/clin.1996.4297","article-title":"Thyroid peroxidase autoantibodies of\u00a0IgE\u00a0class in thyroid autoimmunity","volume":"82","author":"Guo","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2016.04.007_bib84","first-page":"3602","article-title":"A\u00a0possible role of immunoglobulin E in patients with hyperthyroid Graves' disease","volume":"84","author":"Sato","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaci.2016.04.007_bib85","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2006.06.030","article-title":"Serum\u00a0IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients","volume":"180","author":"Mikol","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib86","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00296-007-0494-3","article-title":"Detection of serum IgE class anti-SSA antibodies in mothers with foetal loss","volume":"28","author":"Sekigawa","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaci.2016.04.007_bib87","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaci.2009.05.015","article-title":"Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema","volume":"124","author":"Zeller","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.01.016","article-title":"Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis","author":"Reich","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib89","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/jid.2014.25","article-title":"Cytokine effects induced by the human autoallergen alpha-NAC","volume":"134","author":"Hradetzky","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib90","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0923-1811(01)00084-6","article-title":"Autoantibodies in atopic dermatitis","volume":"25","author":"Muro","year":"2001","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2016.04.007_bib91","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1046\/j.1523-1747.1998.00413.x","article-title":"Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients","volume":"111","author":"Valenta","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib92","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","article-title":"Does \u201cautoreactivity\u201d play a role in atopic dermatitis?","volume":"129","author":"Tang","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40629-015-0037-5","article-title":"Autoallergy in atopic dermatitis","volume":"24","author":"Hradetzky","year":"2015","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaci.2016.04.007_bib94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1346-8138.12464","article-title":"Autoimmunity in atopic dermatitis: biomarker or simply epiphenomenon?","volume":"41","author":"Cipriani","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib95","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1067\/mai.2002.123303","article-title":"IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A\u00a0treatment reflect tissue damage","volume":"109","author":"Kinaciyan","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib96","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4049\/jimmunol.175.2.1286","article-title":"Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity","volume":"175","author":"Aichberger","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib97","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mai.2000.107039","article-title":"Autoantibodies to DFS 70\u00a0kd\/transcription coactivator p75 in atopic dermatitis and other conditions","volume":"105","author":"Ochs","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1523-1747.ep12329617","article-title":"Immunoglobulin E response to human proteins in atopic patients","volume":"107","author":"Valenta","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2016.04.007_bib99","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri1372","article-title":"Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses","volume":"4","author":"Seong","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2015.8","article-title":"Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease","volume":"16","author":"Cao","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2016.04.007_bib101","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/088922202753519142","article-title":"HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in\u00a0vitro","volume":"18","author":"Pellegrino","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaci.2016.04.007_bib102","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/jcm.31.4.819-823.1993","article-title":"Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections","volume":"31","author":"Russi","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaci.2016.04.007_bib103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7150\/ijms.8.239","article-title":"Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine","volume":"8","author":"Smith-Norowitz","year":"2011","journal-title":"Int J Med Sci"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916301907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916301907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:59:59Z","timestamp":1758790799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916301907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0091674916301907"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.04.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726403627.793560320","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of IgE in autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}